Melanie Brooke Bernhardt

31PUBLICATIONS
87CO-AUTHORS
Physical properties of materialsInfant and child healthPharmaceutical delivery technologiesHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|May 06, 2026
Stability of extemporaneously compounded cobimetinib oral suspensions.

|Apr 21, 2026
Impact of Dosing Interval Adherence on Pharmacokinetic Outcomes of Recombinant Erwinia Asparaginase in Pediatric Leukemia or Lymphoma.

|Jan 27, 2026
Pediatric-Friendly Formulations: Critical to Maximizing Benefit of Novel Therapeutics Such as Selumetinib for Children With Neurofibromatosis and Other Neoplasms.

Brooke Bernhardt, Brenda J Weigel

|Oct 25, 2025
Advancing non-sterile pediatric pharmacotherapy through automated compounding and 3D printing of ondansetron hcl dihydrate dosage forms.

Mahsa Bahman, M Brooke Bernhardt, Cynthia A Brasher

|Aug 19, 2025
An analysis of diagnostic metabolomic profiles associated with hepatotoxicity during childhood ALL induction therapy.

Emily J Mason, Anna M Crain, Michael E Scheurer

|Jul 25, 2025
Retraction Note: New recommendations for reversal of high-dose methotrexate cytotoxicity with folinic acid.

Jesper Heldrup, Archie Bleyer, Laura Ramsey

Pageof 6

Frequent Collaborators

6 joint publications

Austin L Brown

5 joint publications

Eric S Schafer

5 joint publications

Laura Ramsey

5 joint publications

Ashley Nicole Chavana